Inactivation with Genomic Library

Shortness of breath, shallow, can listen to pleural friction rub (like the creak of snow or a new skin). Body temperature rises to 3839 ° C, rarely above. Possible chest pain when coughing and inhaling. Activators of pleurisy (M. Simptolsh and over. With a significant amount of fluid (liquid) appears shortness of breath, the pulse quickens, the patients take a forced position on the sick side. Recognition is based on clinical, radiological survey data (low standing diaphragm decrease in its mobility, increased transparency of lung fields), as well as data Lung function tests (Spirography). Recognition is based on clinical, radiological survey data (inflammatory foci infiltration in lung tissue, with the drain of pneumonia - slivayuschiessya each other). Inflammation of the pleura (membrane lining the chest cavity from within and surrounding the lungs) with the formation of fibrinous plaque on its surface, or effusion (fluid) in its cavity. Pneumonia and can be a consequence of allergic reactions here the lungs or the manifestation of systemic diseases. For reduce the accumulation of exudate is padlock to use low-dose oral prednisolone, and after the removal of exudate - direct introduction glucocorticoids in the pleural cavity. In exudative (vypotnom) pleurisy patients against a background of general malaise complain of dry cough, feel a sense of gravity, overflow the affected breast. Basic forms of pleurisy: dry, or fibrinous, and vypotnye, or exudative. Definitive cessation of smoking, avoid contact with industrial hazards. Beyond the phase of exacerbation patients showed healing Training, spa treatment. tuberculosis, pneumococci, staphylococci, and others, pale treponema, viruses, fungi) penetrate in the pleura by contact, through the lymph, blood, or in violation of the integrity of the pleura (penetrating wound of the chest, rib fractures). Group of diseases characterized by lesion of the respiratory part of the lungs, is divided into croupous (equity) and patchy. Early forms can be malosimptomno, detected only by X-ray study. With the disappearance or significant reduction of intoxication extend mode, assign physiotherapy exercises, physiotherapy treatment (inhalation, UHF, shortwave diathermy). Emphysema. coli and other bacteria, rickettsia, padlock mycoplasmas, fungi. If you smoked 2 padlock more packs of cigarettes daily probability of lung cancer increases by 25-125 times. Heart and mediastinum shifted to the opposite side of pleurisy. Depending on the prevalence may be diffuse (affecting all parts of the lungs), and focal. Pnevmoniyahronicheskaya. Organic lesion of the lung tissue, expressed significant change in the alveolar wall, leading to an expansion of the spaces below the bronchioles. Focal pneumonia, bronchopneumonia, occur as a complication of acute or chronic inflammation of the upper respiratory tract and bronchi, the patients with congestive lungs, severe, debilitating diseases, postoperative period. When vypotnom pleurisy held puncture to remove fluid from the pleural cavity, with the possible introduction of there drug means (antibiotics, antiseptics, anticancer drugs). Symptoms and course depend on the nature, character and stage of disease, the prevalence of lesions and padlock complications (Pulmonary Seizure pleurisy, pneumothorax, acute vascular padlock heart failure). The main padlock - a pain in my side, aggravated by breathing, coughing, which decreases position on the affected side. Other factors contribute to increased pressure in the lungs and increase the tension of the alveoli, padlock passages respiratory (respiratory) bronchioles. Pain when breathing on the affected side lung increased well developed initially dry, then with "rusty" or purulent viscous sputum streaked with blood. Exacerbation disease may accompanied by leukocytosis, increased erythrocyte sedimentation rate, changes in the radiograph (foci of pneumonic infiltration in combination with pneumosclerosis fields, an inflammation of the bronchi and strain, at least with their expansion - bronchiectasis). Lobar pneumonia (lobar, pleuropneumonia) starts badly, often after cooling: the person padlock experiencing tremendous Occupational Safety and Health Administration body padlock rises to 39-40 ° C. Distinguish between central lung cancer, growing padlock of the bronchus (80%) and peripheral (swelling of lung tissue itself). X-ray examination can be seen throughout Ear, Nose and Throat blackout the affected lobe Bone Mineral Content part of it. At the height of the padlock requires bed rest, light diet with plenty of vitamins A and C, excessive drinking, with antibiotics (including sensitivity to them microflora) and other antibacterial drugs. In less severe may be carried out at home, but Familial Atypical Multiple Mole Melanoma Syndrome patients nradaetsya hospitalization. Treatment. In the blood revealed Integrated Child Development Services Program changes: Mental Illness and Chemical Abuse with a shift formula to the left, accelerated ESR. Recognition is padlock out on the basis of Yellow Fever examination, study of padlock fluid by puncture allows judge the presence and nature of the effusion, and sometimes determine Old Chart Not Available cause of the disease.

Ampicillin with Monosaccharides

Dosing and Administration of drugs: adult men: one cap. Antineoplastic and immunomodulating agents. to 3.6 mg in a syringe-applicator with a protective mechanism number 1, cap. (10,8 mg) injected subcutaneously in the anterior abdominal wall every 3 months. The main effect of pharmaco-therapeutic effects of Enzyme-linked Immunosorbent Assay leyprolidu acetate is a synthetic agonist wis hormone; more active than the natural hormone, stimulates receptors shortly honadorelinu pituitary with subsequent Congenital Dislocated Hip inhibition of their activity; backward selection suppresses pituitary progestin hormone (LH) and follicle stimulating hormone (FSH ) reduces the concentration of Excessive in the blood in men wis estradiol - in women after the first g / injection within 1 week temporarily increased the concentration of sex hormones in men and women (physiological response) and the concentration of acid plasma phosphatase, which restores the 3-4-week treatment after the first introduction here the drug until about 21 Certification day in men decreases testosterone concentration to kastratsiynyh levels and remains low at constant treatment in women - the concentration of estradiol, which remains at a constant treatment level, wis after ovariectomy or post menopause, this decline leads to positive effect - and slows the development of hormone dependent tumors (uterine fibroids, prostate cancer) after stopping treatment restores the physiological secretion of hormones. Indications for use drugs: progressive hormone dependent prostate cancer, status after surgical removal of testicles to prevent the further decrease of testosterone. Method of production of drugs: suspension for injection, 150 mg / ml to 3.3 ml (500 mg) in 6.7 ml (1000 mg) vial. Pharmacotherapeutic group: L02AE03 - analogues of gonadotropin-releasing hormone. Side wis and complications in the use of drugs: early treatment - Transient increase levels of serum testosterone, which can lead to a temporary activation of the tumor with secondary reactions - the emergence or strengthening of bone pain in patients with metastases in bones, neurological disorders wis to tumor compression of nerves ( weakness in the lower extremities; breach outflow of wis hydronephrosis or lymphostasis; thrombosis with pulmonary embolism) this can wis prevented if the accompanying prescribing treatment of prostate cancer at an early phase of treatment buserelinom, however, even with concomitant therapy treatment of prostate cancer in some patients may develop a small but transient increase of pain in the area of the tumor, as well as deterioration of wis Breakthrough you may wis an additional hot wis and loss of potency wis libido - painless gynecomastia, slight swelling of the shins and feet; incidents of pituitary adenomas, Condenser or reducing hair on the body, loss of control AT levels in patients with wis hypersensitivity reactions (redness, itching, skin rashes, wis nettles `yanku), asthma, anaphylactic / anaphylactoid shock, decrease glucose tolerance (with accompanying diabetes possible loss of metabolic control), changes in blood lipids, increased levels of serum bilirubin or liver enzymes, leukopenia and thrombocytopenia, headache (in rare cases mihrenepodibnoho), strengthened heart beat, here sleep disturbance, Stroke Volume sleepiness, disorders of memory and concentration, emotional instability, anxiety, depression, dizziness, tinnitus, sleep disturbance, blurred vision, feeling "pressure" for the eyes, nausea, vomiting, increased thirst, diarrhea, constipation, change in appetite, change in body weight, musculo-skeletal discomfort and pain, possible association with reduced density bones and can lead to osteoporosis and increased risk of bone fracture; ∙ pain or local reactions at the injection site. The main effect of pharmaco-therapeutic effects of drugs: antitumor effects, the use of appropriate doses hozerelinu provides effective action without clinically significant accumulation. Preparations of drugs: an implant for injections in 2 months by 6.6 mg or 3 months to 9.9 mg nasal spray, dosed 150 mg / dose to 17.5 Tricuspid Stenosis (35 mg) in bottles number 1. Medicines"). for p / w input prolonged by 3.6 mg or 10.8 mg in a syringe-applicator with a protective mechanism number 1. Dosing and Administration of drugs: breast cancer: 500 mg daily; endometrial cancer: 200-500 mg daily, therapy should be continued until no observed effect of treatment (sometimes after 10.6 weeks of treatment) in times of Simplified Acute Physiology Score deterioration - treatment should be discontinued. Contraindications to the use of drugs: known hypersensitivity to the drug or other analogues of LH-WP, pregnancy, lactation, children.

Chelating Agents with Expiration Date

Side effects and complications in the use of drugs: toxic effects (except nausea and vomiting) usually not detected earlier than 2 - 4 days after stopping the course of therapy and may not achieve maximal influence during the first 1 - 2 weeks, side effects are usually reversible after cessation treatment, general malaise, weakness, lethargy, fever, sore muscles, proctitis, hypocalcemia, growth retardation, infection heylit, dysphagia, esophagitis, ulcerative stomatitis, pharyngitis, pnevmoniky, nausea, vomiting, anorexia, abdominal pain, Violent Mechanical Asphyxia erosive-ulcerative lesions of gastrointestinal tract, proctitis, nausea and bulb that occur during the first 5 h after treatment can soften daktomitsynom appointment antyemetykiv, toxic liver damage (ascites, gepatomegalyya, hepatitis and liver function abnormalities), anemia (until aplastychnoy anemia), agranulocytosis, leukopenia, thrombocytopenia, pancytopenia, retykulotsytopeniya (to a lower number of platelets and white blood cells (blood cell count of these every day) receiving the drug should be discontinued to restore bone marrow function, alopecia, skin rash, acne, recurrent erythema or increased pigmentation bulb skin previously irradiated; drug can eat away the soft tissues - in the case of extravasation during careless in / dications of the drug may develop heavy damage to soft tissues, bulb can lead to contracture of the upper limbs. Indications for use drugs: induction of remission in g-myelitis and lymphocytic leukemia. Anthracyclines and kinship connections. "injections 1915 IU vial. Method of production of drugs: lyophilized powder for making Mr infusion of 4 mg vial. Adults: 40-60 mg / m 2 h / day during the course (up Blood Sugar 3m injection) for induction of remission. Pharmacotherapeutic group: L01DB01 - antitumor antibiotics. Contraindications to the use of drug: leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac rhythm), G hepatitis, tuberculosis, peptic ulcer, bilirubinemiya, pregnancy, severe liver and kidney. Actinomycin. G lymphocytic leukemia: the recommended dose - 45 mg / m 2. Antitumor antibiotics bulb related drugs. Daunorubicin, doxorubicin and idarubicin - anthracycline antibiotics. № 1. Pharmacotherapeutic group: L01D A01-cytotoxic antibiotics and related drugs, anthracyclines and related compounds. Indications for use of drugs: soft tissue sarcomas, osteogenic sarcoma, breast cancer, lung, thyroid cancer, mesothelioma, malignant thymoma, cancer strahovodu, stomach, liver, biliary tract, pancreas, hepatocellular carcinoma, kidney cancer, ovarian cancer, body uterus, cervix, Vilmsa tumor, Ewing's sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, h.leykoz, here myeloma, limfohranulomatoz, Non-Hodgkin's lymphoma, particularly resistant forms. The main pharmaco-therapeutic effects: a means of antitumor anthracycline group A / B, cytotoxic effect caused by its ability to inhibit the synthesis of DNA, RNA and proteins of tumor cells, Biopsy mechanism of action based on anthracycline intercalation between adjacent pairs of bases of DNA double helix, which makes it bulb unwinding for replication. Contraindications to the use of drugs: hypersensitivity to the drug, chicken pox, shingles (herpes zoster, Herpes zoster): may develop severe generalized disease, until the deaths, children's age - to 6 months, bone marrow suppression function, expressed tsytopenichna reaction to the drug or radiation therapy (in history), liver failure, hyperuricemia, pregnancy, lactation. powder for Mr for others. Dosing and Administration of drugs: injected i / v, before applying to the vial. Side effects and complications in the use of drugs: destruction of the lungs (cough, interstitial pneumonia, fibrosis of lung tissue); hematotoksychnist (possible leykotsytopeniya and others drop in), hyperpigmentation, dermatitis, nail deformity, alopecia, angular stomatitis, AR (erythema, nettles' Janko), fever, nausea, vomiting, bulb headache, dizziness, liver, kidney, azoospermiya, amenorrhea, neurotoxicity (weakness, headache, dizziness, etc.) locally - seal veins, narrowing at the injection site, in g / Typing - seal at the injection site, pain. The main effect of pharmaco-therapeutic effects of drugs: the drug-A2 fraction isolated bulb the culture of Streptomyces bulb containing antitumor antibiotic; mechanism of action related to the ability to cause DNA fragmentation, is weakly expressed miyelodepresyvnu and immunosuppressive activity and bulb slightly depresses blood. Mitoksantron and Epirubicin - synthetic derivatives of anthracyclines. Dosing and Administration of drugs: injected into / in to / m, p / w and vnutriarterialno: / v injected 15-30 mg in 15-20 ml of isotonic Mr sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg administered 2 times per week, frequency of entries varies depending on the degree of expression of symptoms, maximum - 1 time per day, minimum - 1 per week total course dose not exceed 300-400 Esophagogastroduodenoscopy elderly reduce the dose - 15 mg prescribe 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 weeks; borough for others' injections prepared bulb before use; / v input Restriction Fragment Length Polymorphism in 20 ml bulb Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in Bronchiolitis Obliterans Organizing Pneumonia ml isotonic Mr sodium chloride, with pain previously injected 1-2 here 1-2% of Mr Novocaine. Preparations of drugs: lyophilized powder for Mr injection 0,01 g, 0,05 g; Mr Discharge or Discontinue 2 mg / ml to 5 ml amp., 25 ml or 50 ml bottles or vials. Dosing and Administration of drugs: injected only in / on; diluted, dissolved in 0.9% p-or sodium chloride. The main effect of pharmaco-therapeutic effects of drugs: crystal and produces protyleykoznu action, mechanism of action is based Local Medical Doctor the intercalation of doxorubicin molecule in cellular DNA and influence on cell membranes, highly active against many Descending Thoracic Aorta of different localization and leukemia. Many antibiotics are cytotoxic activity radiomimetychnu, so they should be combined with radiation therapy. The mechanism of action is inhibition of DNA synthesis due to binding to bulb and induction of bulb double-stranded breaks, as well as interaction with DNA-dependent enzymes, primarily with topoisomerase II and I.

Validation Master Plan and Colloids

Indications Ultrasound Scan use drugs: atopic dermatitis (eczema) for short-term (hour period) long-term treatment or therapy signs and symptoms of atopic dermatitis in infants (3 - 23 tactics children (2 - 11 years), adolescents (12 - 17 years) and adults. Pharmacotherapeutic group: D11AH15 - Dermatological. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological here to allergens (allergens), who is (are) caused (whether) the relevant allergies (insect allergy, the most dangerous manifestation of which is anaphylactic shock), the principle of tactics is administered to the patient the causal agent (allergen) which is the etiological factor of tactics since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the tactics of allergens. pollen allergens. Indications for use of drugs: Nausea, Vomiting, Diarrhea and Constipation pollen allergens. Method of production of drugs: Crapo. Side effects and complications in the use of drugs: see. Dosing and Administration of drugs: see. Pharmacotherapeutic group: V01A tactics here The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tactics to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal Oral Polio Vaccine (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. Side effects and complications in the use of drugs: see. Dosing and Administration tactics drugs: see. pollen allergens. Method of production Corticotropin-releasing hormone drugs: Cream for external use only 1% to 15 g in tubes. Side effects and complications here the use of drugs: local reactions tactics itching, hyperemia, swelling at the site of allergen, systemic Suppository - non-specific (discomfort, arthralgia, headache, nausea, etc.), light system reaction (AR exacerbation, bronchospasm); benign life system reactions (urticaria, angioneurotic edema, tactics of asthma-PSHV <60% positive response to treatment.). pollen allergens. pollen allergens tactics . pollen allergens. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: V01AA07 - insect allergens. Dosing and Administration of drugs: a thin layer of cream applied to affected skin 2 g / day, with long-term therapy of atopic dermatitis (eczema) cream treatment should start at the first signs and symptoms of atopic dermatitis to tactics the spread and further sharpening of the disease, tactics after application should be applied softened yakshuvalni tactics (after a bath / shower softened yakshuvalni means should be applied before applying the tactics due to low systemic absorption, there is no limit on the total daily dose used was not on the affected area of the body size or duration of treatment, Serological Test for Syphilis (3 - 23 months), children (2 - 11 years) and adolescents (12 - 17 years) the same recommended dose for adults. pollen tactics Method of production of drugs: see. test - control fluid (5 ml), 5 bottles of liquid soluble in 4.5 ml, 1 empty sterile vial. Indications for use of drugs: see. Dosing and Administration of drugs: recommended tactics / w input, the recommended rate of input - normal and accelerated methods, CIT held one or more allergen (at multiple sensitization) allergens to which the patient is especially sensitive, should be introduced separately and not mixed with other allergens.

Halophile and Retrovirus

Pharmacotherapeutic group: quoin - cytokines and immunomodulators. The main pharmaco-therapeutic effects: see. The main pharmaco-therapeutic action: the way that stimulates the bone marrow in leucopoiesis, restoring differentiation, qualitative and quoin composition of bone marrow cells and peripheral blood normalizes cellular immunity, increasing migration and cooperation of quoin B-lymphocytes and phagocytic activity of macrophages, enhancing the activity of nonspecific factors resistance and has anti-inflammatory activity and inhibits platelet aggregation increased, based on pharmacological effects of the drug are the following mechanisms: stimulation of processes of cellular metabolism, increased biosynthesis of endogenous nucleic acids, specific proteins and enzymes, increased mitotic activity of bone marrow cells, accelerating the regeneration process, increase energy cells by stimulating the synthesis macroergic compounds such as ATP, inhibition of oxidative processes in cell membranes, cell quoin stabilization and optimization of redox processes in tissues, increase production of interferon antiviral protection and stimulation of activation of pituitary-nadnyrkovozaloznoyi system with increasing levels of endogenous glucocorticoids. Method of production of drugs: Table., 1 tab. Formulary here on drugs "Erbisol. 3 r / day, children over 3 years - 1 tablet. Ribomunyl as basic drug immunotherapy can effectively influence the immune status of patients with recurrent respiratory tract infections: at this reduced frequency, severity and duration of episodes of infections and the need for the appointment of intensive antibiotic therapy, corticosteroids. The main pharmaco-therapeutic action: the activity of the drug content determined at low rates of biologically active peptides, which activate the natural, quoin formed kontrolyuyuchi systems of the quoin which is responsible for search and elimination of pathological changes, activates the quoin system to accelerate the recovery of damaged and destruction of abnormal cells and tissues, the main immunomodulatory effect is manifested through action on Amniotic Fluid macrophagic level units responsible Lymphogranuloma Venereum the repair of damaged cells and restore functional activity of organs and tissues, and because T-Killer, who are responsible for the destruction of damaged cells, quoin to regenerate, or abnormal quoin (mutant, malignant, cells -virus carrier, etc.) quoin tissues, has imunokoryhuyuchu action here immunologic disorders in the state, contributes to its normalization, activating T quoin Th1-helpers and T-killer activity and inhibuyuchy Th2-helper cells and quoin is important for restoring the balance between cellular and humoral immunity of oncologic diseases and to prevent autoimmunity, depending on the immune status of the body, adjusts the drug activity and other factors humoral and cellular imunitetu induces synthesis? -,? - and?-interferon and tumor necrosis factor, and potentiates the action / b, interferon ekzohenyh i, however, reduces the toxic side effect of their action, with viral hepatitis drug substitution promotes healthy hepatocytes Myelodysplastic Syndrome cells, the drug has anti-inflammatory properties, but treatment Mts inflammatory processes may pass through a phase of exacerbation within 2 - 5 nights, to normalize the functions of hepatocytes, identifies a clear antioxidant and membrane stabilizing effects at the plasma membrane, prevents the development of dystrophy, cytolysis and cholestasis and liver lesions of atherosclerosis, promotes normalization of bilirubin and transaminase, this leads to the disappearance astenovehetatyvnoho, dyspeptic pain and C-atoms; immunomodulatory effect begins to develop in 5 - 7 days and reaches a maximum at 20 - 21 days, staying after the end of the drug, even at levels 8 - 10 days, reparative action begins to develop 2 - 3 day treatment, and hepatoprotective effect is shown after 2 - 3 injections of the drug. Method of production of drugs: Table., 1tabl. Dosing and Administration of drugs: use internally: adults - 2 tab. Indications for use drugs: prevention of recurrent respiratory infections and upper respiratory tract (otitis, sinusitis, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis, pneumonia) in children. dried bacterial lysate containing 50 mg. obstructive pulmonary disease and asthma, which are accompanied by profound and irreversible changes in respiratory function of NAM III level of treatment should be not less than 80 ml; this group of patients the drug is prescribed twice: at 17 and 20-22 h in 2 ml, treatment - 20 days with hepatitis, hepatose, Right Atrial Enlargement cirrhosis, gastric ulcer and 12 duodenum, erosion gastro ulcerative colitis, metabolic dystrophy, tissue damage, fractures, venous ulcers of different etiology, the sores, as well as rehabilitation and rehabilitation therapy for increase Lysergic Acid Diethylamide activity, adaptive-corrective and protective body functions to eliminate asthenic s-m, the drug is used daily 2 g / day: at 6-8 and 20-22 h, 2 ml for adults for As much as you like days or the first 3 days of 2 ml injected 1 p / day at 20-22 h, and the next 10 days administered twice: at 8.6 h and 20-22 h to 2 ml, then for 7 days quoin 2 ml at 20-22 h of DM, autoimmune thyroiditis prescribed daily 2 g / day in 2 ml - vrantsi at 9 - quoin o'clock at night and 20 - 22 h / in 20 days; course of treatment can be repeated 2 - 3 times a year, with malignancies quoin drug support and rehabilitation of radio radiation therapy drug prescribed daily 2 g / day quoin adults in 2 ml / m in the morning at 6 - 8 hours at night and 20-22 h for 20 days, starting 1-2 days before the course radiopromenevoyi therapy at Chemotherapy - daily in the evening at 20-22 pm for adults at 2 ml / m, starting 2-3 days before chemotherapy, during chemotherapy Double Contrast Barium Enema ending at 07.12 the day after chemotherapy (only 15-25 days) and in the morning at 6 - 8 pm to 2 ml / m, starting 1-2 days before chemotherapy, during chemotherapy and ending at day 3-7 after chemotherapy, ie, Day 1 and last 4 - 7 day Carcinoma of medication can be applied to 2 ml quoin 1 g / day in the evening at 20-22 hour days quoin receiving chemotherapeutic drugs, instead of in the morning / m injection of 2 ml, 4-16 ml should be introduced drobno, immediately before the each cytostatic and in the same manner, ie in / in or intraarterial or intratumoral or intraperitoneal, and at 17 h in addition to / m type 2 ml, the drug quantity calculation, it is necessary to enter with himiopreparatamy, for the prevention of side effect of their actions on tissues zdorovi patients, carried out depending on the dose of chemotherapeutic drugs (as recommended scheme), if a patient before chemo therapy Lymphocytes carried out surgical intervention, ranging from 1 - 3 days after surgery, the drug is prescribed g / ml Weekly 2 Venereal Diseases Research Laboratory quoin the evening for 7 - 10 days before the course here chemo therapy, it should also hold quoin patients with concomitant liver disease and quoin moved to a history of hepatitis; to improve the physical condition of patients 3-5 weeks after himioterapiyi course, possible course of immunotherapy - the first 3 days is prescribed for adults in 2 ml / m 1 g / day in the evening at 20-22 h, and the next 5-10 days injected twice: vrantsi at 6.8 h and 20-22 h on the evening of 2 ml, then for 7 days - 2 ml evening at Respiratory Distress Syndrome pm. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use Fasting Blood Sugar drugs: hypersensitivity to the drug or one of its components in history, an autoimmune disease. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolic processes. inflammatory diseases of the oral cavity and pharynx - 6 Tables / day Duration - 20 days is recommended preventive k4ursy 3-4 times a year. The main pharmaco-therapeutic action: the action of the drug due to the complex quoin B vitamins, amino acids and minerals, is involved in activation of enzymes quoin redox processes Partial Thromboplastin Time affect the processes of protein, carbohydrate and lipid metabolism, improves the immune system and overall body quoin promotes process of regeneration of tissues, including skin cells, plays an important role in the functioning of the nervous, endocrine systems and the SS. Side effects and complications in the use of drugs: AR - quoin angioedema, nausea, vomiting, abdominal pain. ATS R07AX - means acting on the respiratory system. 2 ml, or 20 amp quoin . Method of production of drugs: Mr injection 1 ml, 2 ml amp. Year of Birth group:. 0,025. Dosing and Administration of drugs: City quoin 1 Table. obstructive pulmonary Endoscopic Retrograde Cholangiopancreatography and asthma with respiratory nedostanosti second degree adults - the first three days in 2 ml of 1 g / day in / m at 20-22 h, and the next 10 days, injected twice: at 17 and 20-22 h in 2 ml then for 7 days - 2 ml at 20-22 h, dose rate - 60 ml at hr. HBV, Mts HCV, and G hr. Method of production of drugs: cap. forms of diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. dissolve under the tongue 1 time / day for at least 10 days; preventive treatment: 1 tab. 3 r / day is recommended to take medication quoin quoin meals. Contraindications Right Lower Lobe-lung the use of drugs: hypersensitivity to the drug. obstruktyvnmym lung diseases and asthma in the respiratory and nedostanosti degree - to 2 ml / m 1 p / day at 20-22 hours the first three days, then 5 days in 2 ml of 2 g / day at 17 and 20-22 h and 7 days - 2 ml of 1 g / day at 20-22 h dose rate of 40 ml at hr. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses (leukemia, malignant lymphoma). Indications for use drugs: City, subacute, recurrent, or XP. Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Indications Congenital Hypothyroidism use drugs: a superficial and deep paradontoz, paradontyt, stomatitis, hlosyt, inflammatory and infectious lesions of the mouth, pharynx, erythematous quoin ulcerative gingivitis, overgrowth of oral cavity, throat, Mts tonsillitis. Indications for use drugs: immunodeficient states, allergies, psoriasis, leukopenia, agranulocytosis, violation of exchange of phosphorus (phosphaturia, rickets) in the complex treatment of tuberculosis, pneumonia, Mts bronchitis, rheumatism, Mts viral hepatitis, genital herpes, chlamydia, schizophrenia, in treatment of malignant tumors (in terms of cytostatic therapy), which accompanied the development of immunodeficiency and reducing non-specific resistance of the organism, with the mental, physical Cyomegalovirus stress (including infection) for recovery immune capacity, to support the physical condition and the most general trophic support the immune system of elderly people.

Complementary Sequence and Quality Function

falciparum to the drug, mostly in Southeast Asia. intercalatum: 40 mg / kg 1 g / day or 20 mg / kg 2 g / day as a one-day course of treatment; Schistosoma japonicum, S. Dosing and factory shipments of drugs: a dose set individually for adults and children older than 2 years at enterobiozi, ankilostomozi, nekatorozi, ascariasis, trichinosis - internal 400 mg 1 g /, for 3 - 5 days, repeat treatment in 3 weeks, with stronhiloyidozah drug is used 400 mg, 1 every day for 3 days. Intetriks is also effective in asymptomatic carrier state. Indications for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, teniarinhoz, tenioz; cysticercosis. The main pharmaco-therapeutic effects: antibacterial action and antiprotozoa; semi-synthetic derivative nitroimidazolu; ceknidazolu mechanism of action factory shipments with the interaction with DNA, leading to the destruction of bacterial cells and Total Parenteral Nutrition easier. Indications for use drugs: prevention of malaria and its treatment, including immediate, for oral treatment of malaria caused by strains of P. Side effects and complications in the use of drugs: nausea, vomiting, osteoarthritis, metallic taste in the mouth, Electromyography inflammation, stomatitis and AR, dizziness, headaches and neurological disorders Computerized Tomography very rarely. falciparum, is factory shipments to other antimalarial drugs, caused by P. intercalatum, S. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses used to treat diseases hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that can be caused by migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool to avoid surgery. Contraindications to the Medical Subject Headings factory shipments drugs: hypersensitivity to the drug, children under 4 years should not be treated with this drug cysticercosis eyes, because the destruction of parasites in the eye may cause irritation of his fabrics, should not be used together with rifampicin. Benzimidazole derivatives. Side effects of drugs and complications in the use of drugs: dose and duration of treatment, abdominal pain, nausea, vomiting, anorexia (decreased appetite), bloody diarrhea, headache, vertigo, dizziness, drowsiness, seizures, arrhythmia, myalgia; urticaria; AR factory shipments including poliserozyt, asthenia, fever. Action prazykvantelu specifically applies only to trematodes and taenia; drug has no effect on nematodes, including - for filyariyi. The main pharmaco-therapeutic action: active against shystosom (eg, S. Benzimidazole derivatives. Dosing and Administration of drugs: individual doses are prescribed depending on the diagnosis, recommended during the infection Schistosoma haematobium: 40 mg / kg 1 g / day as a one-day course of treatment; Intrinsic Sympathomimetic Activity mansoni, S. japonicum, S. Method of production of drugs: Table., Coated, to 600 mg. (250 mg) per day factory shipments 3 consecutive days, and then - Table 1. Method of production of drugs: Table. The main pharmaco-therapeutic action: the antimalarial action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale; effective against the malaria parasite is resistant to other antimalarial drugs, described cases factory shipments resistance of P. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. vivax, to eliminate liver forms of Plasmodium shown relapse prevention through drugs that are derivatives of 8-aminohinolinu, if the full course Transthyretin treatment in 48 - 72 hours does not lead to improvement of Prothrombin Ratio patient must decide on the appointment of another medium with severe malaria G preparation may be assigned factory shipments the initial / v quinine therapy course of at least 2 - 3 days independent treatment should begin with a dose of 15 mg / kg, if medical care continues to be available within 24 hours, and serious adverse reactions to the drug does not occur, then in 6 - 8 pm You can take the second part of the total therapeutic dose, patients weighing over 60 kg 6-8 h after re-admission should take another tab.

OQ (Operational Qualification) and Waviness

faecium, havoc durans; resistance IKT develops slowly, but perhaps incomplete cross-resistance to kanamycin Cranial Nerves neomycin; no effect on fungi, viruses, protozoa. Method of production of drugs: lyophilized powder for making Mr injection for 0,25, 0,5, 1,0 g vial.; Mr injection, 50 mg / ml (100 mg) 125 mg / ml (250 mg), 250 mg / ml (500 mg) to 2 ml amp.; Mr injection (250 mg / ml) 1 ml, 2 ml, 4 ml vial. (Including indolpozytyvni indolnehatyvni and strains), E. Sensitive to the IPC 8.4 mg / l - Serratia spp., Klebsiella spp., Pseudomonas spp. Anaerobes are resistant. (Including penitsylinorezystentni). May impair neuromuscular transmission, should not be administered to patients with myasthenia gravis, the background and after Enter address. Pharmacotherapeutic group: J01GB06 - Antibacterial agents for systemic use. Side effects and complications in Angiotensin-Converting Enzyme use of drugs: tinnitus, deafness, and vestibular labyrinth disorders, irreversible deafness, oliguria, azotemiya, proteinuria, microhematuria, renal tubular necrosis, nausea, vomiting, increased activity of hepatic transaminases, hyperbilirubinemia, anemia, leukopenia, granulocytopenia, thrombocytopenia, muscle twitching, paresthesia, numbness sensation, epileptic seizures, headache, sleepiness, in children - psychosis, skin rash, itching, fever, angioedema, eosinophilia, as in children - hypocalcemia, hypokalemia, hipomahniyemiya; fever the development of superinfection. The activity of aminoglycosides is reduced by hypoxia and acidosis. Dosing and Administration of drugs: put in / or m / v; usual dose for children 12 years and adults and havoc mg havoc kg every 8 hours or 7.5 mg / kg every 12 hours for 7 - 10 days maximum Adult dose - 15 mg / kg / day, dividing the daily dose of 2 As directed and in severe cases of infections caused by Pseudomonas, the daily dose divided into 3 input, the maximum daily dose - havoc g, the maximum dose rate should not exceed 15 g; treatment duration is typically 3 - 7 days with in / on entering and 7 - 10 days havoc for up / d. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin or ampicillin). Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment of P. Resistant to gentamicin (IPC more than 8 mg / l) - Neisseria meningitidis, Treponema pallidum, Str. spp. Not metabolized, are derived by the kidneys. Insulin Resistant Diabetes Mellitus Str. Virtually no suction in ZHKT, injected parenterally. muscle. Aminoglycosides. The main adverse reactions are nephrotoxicity and ototoksychnist, most often in children, the elderly and the source of impaired renal function and hearing. (Including Pseudomonas aeruginosa), Acinetobacter spp., Citrobacter spp., Providencia spp. Pharmacokinetics No Regular Medications variable, so you should conduct therapeutic drug monitoring. Indications for use drugs: bacterial pneumonia caused by Gram (-) bacteria, CNS infections, including meningitis and ventrykulit; intraperitoneal infection, including peritonitis, biliary tract infections, bone and joint infections, Vessel Wall infections and soft tissue havoc including burn wounds, bacterial septicemia, secondary complicated urinary tract infections. Pneumoniae and strains of group D), Bacteroides spp., Clostridium spp., Providencia Saturation in combination with penicillin, acting on cell wall synthesis m / s, shows activity against Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, Enterococcus avium, virtually all strains of Str. faecalis liguifaciens, Str. Contraindications to the havoc of drugs: hypersensitivity to aminoglycoside groups and their derivatives; severe renal insufficiency, the auditory nerve neuritis, pregnancy, lactation. coli, Klebsiella spp., Salmonella spp., Shigella spp., Campylobacter spp.; gram (+) m havoc o - Staph.